unitedbiopharma.com

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/Overview.htm

UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/about-us.htm

UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. Our platform technologies from molecular and cellular engineering of high yield antibody and protein production of specific products by CHO cells are also being used to develop a line of biosimilar and biobetter versions of widely used protein and antibody drugs whose patents are about to expire. Additional re...

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/Ub-311.htm

UB-311 is a novel immunotherapeutic for the treatment of Alzheimer’s Disease (AD). The UBI vaccine employs the. Helper T cell technology and a particular site-specific epitope to target the amyloid-beta peptide. UB-311 has successfully completed clinical Phase I study, demonstrating safety and tolerability. UBI is initiating a Phase II study.

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/Hiv-vaccines.htm

UBI has two HIV vaccines in development. Our first product, UBI HIV-RC vaccine, is an investigational. Our second product, UBI HIV gp120, is an immunotherapy of HIV intended as a preventative vaccine for uninfected people and as an immunotherapeutic vaccine for infected people. Its primary active ingredient is an investigational. Immunogen induces an anti-HIV antibody response that blocks HIV from binding to the CD4 cell surface receptor, thereby inhibiting the initial step that leads to HIV infection.

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/Publications.htm

UBI Publications by Field. Review publication of UBITh technology and products. 1 Wang CY, Walfield AM. Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, and for veterinary applications. Vaccine 2005, 23:2049-2056. Aβ Immunotherapeutics (Alzheimer Disease). 1 Wang Y, Finstad CL, Walfield AM, Sia C, Sokoll KK, Chang TY, Fang XD, Hung CH, Birgit H-P and Windisch M. Site-specific UBITh. Severe Acute Respiratory Syndrome (SARS). Allergy, Including Vaccine. 3 Shen F, ...

ubiocmo.com

UBI Gruop CDMO Services, contract manufacturing organization (CMO) that provides services in bio CMO, biologics CMO, protein drugs CMO, and GMP manufacturing.

http://www.ubiocmo.com/sub5.html

Process development for biologics. Formulation development for pharmaceuticals. UBI group of companies. Business center:11049, 52E, No.7 Xin Yi Rd. Sec. 5, Taipei, Taiwan (R.O.C.). Tel: 886-2-8101-0101 # 1860. United Biomedical, Inc.,. Corporate Headquarters : United Biomedical, Inc. 25 Davids Drive Hauppauge, NY 11788. Tel: 886-2-8101-0101 # 1860. Contact: Dr. Roger Kuo, roger.kuo@ubi-pharma.com. Peter Tang, peter.tang@unitedbiopharma.com. Process development for biologics.

ubiasia.com.tw

聯亞生技開發

http://www.ubiasia.com.tw/News/Default.asp?SN=160&Sort_Number=0&Page=1&RecordCount=52&Keyword=

更多資訊請至: www.unitedbiopharma.com. PR@mail.ubiasia.com.tw. 總管理處及二廠地址 30351新竹縣湖口鄉光復北路45號 電話 (03)598-4151 傳真 (03)598-1173 E-mail PR@mail.ubiasia.com.tw. 研發中心 R&D Center 30351新竹縣湖口鄉光復路1號 電話 (03)597-7373 傳真 (03)597-2323. 企業總部 11409 台北市信義區信義路五段七號52樓E室 Tel:886-2-8101-0101 Fax:886-2-8101-0100. Rm E, 52F., No.7-5, Sec. 5, Xinyi Rd., Xinyi Dist., Taipei City 11049, Taiwan (R.O.C.).

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/pipeline.htm

UBI has a robust pipeline of immunotherapeutic candidates and discovery programs built around our proprietary technology platforms and functional antigenic approach, in both human and animal applications.

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/Partnership.htm

In order to maximize the potential of our pipeline and bring our therapies to the market as quickly and efficiently as possible, UBI seeks pharmaceutical partners to facilitate the late-stage development and commercialization of our products in certain therapeutic areas. We welcome inquiries from interested companies wishing to discuss partnering opportunities with us.

unitedbiomedical.com

United Biomedical, Inc.

http://www.unitedbiomedical.com/Locations.htm

UBI is headquartered in Hauppauge, NY with operational divisions in Taipei and Hsin-Chu, Taiwan and Shanghai and Beijing, China. UBI’s China operations are located in 168,000 SF in Shanghai’s premier ZhiZhu Science Park. The new UBI-China base includes facilities for the manufacture of API peptides, for manufacturing human and animal vaccines and diagnostics, and for R&D support activities. This facility was approved by the Ministry of Agriculture, PRC for GMP compliance in 2007.